These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1875284)

  • 21. A method for calculating the mean transit times and distribution rate parameters of metabolites without separate intravenous administration of metabolite.
    Cheng H
    J Pharm Sci; 1992 May; 81(5):488-90. PubMed ID: 1403688
    [No Abstract]   [Full Text] [Related]  

  • 22. A New Method for the Estimation of Absorption Rate Constant in Two-Compartment Model by Extravascular Administration.
    Zeng Y; Liu J; Liu W; Jiang S; Wang S; Cheng Z
    J Pharm Sci; 2020 May; 109(5):1802-1810. PubMed ID: 32032589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mean time parameters for generalized physiological flow models (semihomogeneous linear systems).
    Verotta D; Sheiner LB; Beal SL
    J Pharmacokinet Biopharm; 1991 Jun; 19(3):319-31. PubMed ID: 1875285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An algorithm and computer program for calculating the mean transit time and distribution rate parameters of generated metabolites undergoing linear tissue distribution and linear or non-linear central elimination.
    Cheng H; Yu C; Jusko WJ
    Biopharm Drug Dispos; 1994 May; 15(4):273-94. PubMed ID: 8068866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of direct search optimization for pharmacokinetic parameter estimation.
    Khorasheh F; Sattari S; Gerayeli A; Ahmadi AM
    J Pharm Pharm Sci; 1999; 2(3):92-8. PubMed ID: 10953255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Development and identifiability analysis of parent-metabolite pharmacokinetic model for risperidone and its main active metabolite 9-hydroxyrisperidone].
    Ding JJ; Jiao Z; Yu YQ; Shi XJ
    Yao Xue Xue Bao; 2007 Jun; 42(6):631-8. PubMed ID: 17702401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Types of mean residence times.
    Wagner JG
    Biopharm Drug Dispos; 1988; 9(1):41-57. PubMed ID: 3342284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Validation of a new procedure for calculating tissue/blood distribution coefficient].
    Manuĭlov KK; Gefter IuV
    Antibiot Khimioter; 1991 Mar; 36(3):49-50. PubMed ID: 1877880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A minimax approach to the single-point method of drug dosing.
    Bahn MM; Landaw EM
    J Pharmacokinet Biopharm; 1987 Jun; 15(3):255-69. PubMed ID: 3668803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of choosing a correlation structure on model selection and parameter estimation.
    Jain L; Jadhav P; Gobburu J
    Int J Clin Pharmacol Ther; 2014 Jul; 52(7):598-611. PubMed ID: 24725444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients.
    Hennig S; Wainwright CE; Bell SC; Miller H; Friberg LE; Charles BG
    Clin Pharmacokinet; 2006; 45(11):1099-114. PubMed ID: 17048974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial slope technique for estimation of the apparent volume of distribution during constant-rate intravenous infusion.
    Cocchetto JF; Cocchetto DM; Bjornsson TD; Bergan T
    J Pharm Sci; 1984 Jan; 73(1):58-62. PubMed ID: 6694084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetics of clofarabine and its metabolite 6-ketoclofarabine in adult and pediatric patients with cancer.
    Bonate PL; Cunningham CC; Gaynon P; Jeha S; Kadota R; Lam GN; Razzouk B; Rytting M; Steinherz P; Weitman S
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):875-90. PubMed ID: 20582417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral and IV dosing: a method to determine the compartment of drug elimination for two-compartment models.
    Yates JW; Arundel PA
    J Pharm Sci; 2008 Jun; 97(6):2036-40. PubMed ID: 17847075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of various models of hyaluronan kinetics for assessment of liver function.
    Lindqvist U; Groth T; Lebel L
    Scand J Clin Lab Invest; 1997 Feb; 57(1):49-58. PubMed ID: 9127457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel method of calculating absolute bioavailability in nonlinear pharmacokinetics.
    Veng-Pedersen P
    J Pharm Sci; 1985 Jan; 74(1):90-3. PubMed ID: 3981428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationships between half-life (t1/2) and mean residence time (MRT) in the two-compartment open body model.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 May; 25(4):157-62. PubMed ID: 15108218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel extravascular input function for the assessment of drug absorption in bioavailability studies.
    Weiss M
    Pharm Res; 1996 Oct; 13(10):1547-53. PubMed ID: 8899849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kinetics of sequential metabolism. Contribution of parallel, primary metabolic pathways to the formation of a common, secondary metabolite.
    Pang KS
    Drug Metab Dispos; 1995 Feb; 23(2):166-77. PubMed ID: 7736907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.